Accenture plc (ACN)
NYSE · Price as of · Nasdaq Real Time Price
- Profitability13/20
Profitable but shrinking: $7.79B over the last four reported quarters, down from $7.95B the year before.
- Insider buying vs selling11/20
Insiders are sellers only: 1 sell worth $11,966, no open-market buys, across the last 20 Form 4s. Routine executive selling is common, so this is only a mild negative. Separately, 1 new 5%+ stake disclosure (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings4/15
2 offering-related filings in the last year (share-count history unavailable).
- Analysts25
- Implied upside-2.9%
- Target range$130.00 to $275.00
- EPS expected$3.18 +4.9%
- A year ago$3.03
- Revenue expected$18.04B +2.5%
- Estimate range$3.12 to $3.23
ACN closed at $189.61 on Aug 28, up 16.1% since Jul 30. Chart read: price above the 50-day moving average but below the 200-day; the 50-day is below the 200-day (downtrend structure); trading at 40% of the 52-week range ($124.44 to $288.54).
Insider buying and selling at Accenture plc (ACN)
The most recent Form 4 on record for Accenture plc (ACN) is July 30, 2026, when Joel Unruch, General Counsel/Corp Secretary, sold $1.7M of stock. That sale ran under a pre-arranged 10b5-1 plan, so it was scheduled ahead of time rather than decided that week.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Joel Unruch · General Counsel/Corp Secretary | Sell | $1.7M | July 30, 2026 | Routine |
| Julie Spellman Sweet · Chair and CEO | Sell | $1.5M | February 10, 2026 | Routine |
| Julie Spellman Sweet · Chair and CEO | Sell | $2.3M | October 29, 2025 | Routine |
| Julie Spellman Sweet · Chair and CEO | Sell | $2.2M | October 22, 2025 | Routine |
| Manish Sharma · Chief Strategy & Services Ofcr | Sell | $1.7M | October 22, 2025 | Routine |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| Unruch Joel · Officer | $1.8M | July 30, 2026 | Executed | Routine |
How Congress has done in ACN
Every purchase of ACN disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.
| Measure | ACN | SPY |
|---|---|---|
| Median 12-month return after purchase | -1.7% | +22.2% |
| Median difference vs SPY | -15.7% | — |
| Purchases that beat SPY | 3 of 27 (11%) | — |
| Members who bought | 11 | — |
Most frequent buyers: Kevin Hern (12), Jared Moskowitz (3), Scott Franklin (3), Lois Frankel (2), Daniel Goldman (1).
These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 4 of the 27 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-08-11 | Kelly Louise Morrison MN | Sale | $1,001 - $15,000 | |
| 2026-08-11 | Kelly Louise Morrison MN | Sale | $1,001 - $15,000 | |
| 2026-08-11 | Kelly Louise Morrison MN | Sale | $15,001 - $50,000 | |
| 2026-07-10 | Dan Newhouse WA | Purchase | $1,001 - $15,000 | |
| 2026-06-16 | Gil Cisneros CA | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4/A | August 24, 2026 | FORM 4/A |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
| 4 | August 17, 2026 | FORM 4 |
Frequently asked questions
When does ACN report earnings?
Accenture plc (ACN) is scheduled to report quarterly results on October 1, 2026, before the open. The 20-analyst consensus is $3.18 per share on revenue of $18.04B for the quarter ending August 31, 2026, against $3.03 and $17.60B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.
What do analysts expect for ACN?
25 analysts cover Accenture plc (ACN). The consensus rating is Buy. The average price target is $184.19, in a range of $130.00 to $275.00.
Are insiders buying or selling ACN?
We track Form 4 filings for Accenture plc (ACN). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Has Congress made money trading ACN?
11 members of Congress have disclosed buying ACN in the last 5 years, 27 purchases in total. Measured over the 12 months after each trade date, the median purchase returned -1.7% against +22.2% for SPY over the same windows, and 3 of the 27 (11%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.
Where can I see ACN SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4/A filed August 24, 2026.